Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 AUD | +2.64% |
|
+7.64% | -15.94% |
May. 28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
May. 27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- MarketScreener Editorial Features